Patients who have overdosed on drugs commonly present to emergency departments, with only the most severe cases requiring intensive care unit (ICU) admission. Such patients typically survive hospitalisation. We studied their longer term functional outcomes and recovery patterns which have not been well described.
While drug toxicity and poisoning are common causes of attendance at emergency departments, only a minority of such patients require intensive care unit (ICU) admission. Surveillance data from the United States found that 3% of toxic exposures required critical care management 1 . Such cases represent the most severe end of a broad continuum of presentations and typically exhibit life-threatening toxic syndromes ('toxidromes'), with overlapping clinical features 2 . Deep coma, cardiac arrest or aspiration injury in a young person are classical presentating features. Commonly, the patients have underlying good physical health while collateral histories often describe a propensity for high-risk behaviour or even deliberate self-harm 2, 3 . Psychiatric and addiction issues are common, as are recurrent overdoses 3 .
That the literature on this patient group is heavily dominated by case reports is unsurprising, since each case presentation can be regarded as a unique pharmacological challenge. Hence, high-quality prospective trials would appear difficult to perform. In addition, the few outcome studies that exist are focused on short-term measures (typically survival) 3 . We believe this is a significant limitation to the present literature. Despite their youth and good health, the tendency of these patients to high-risk behaviour could be expected to persist. Conversely, one might hope that many of these patients would alter their lifestyles after such a life-threatening event. However, to our knowledge, this question has not been addressed previously.
One major current trend in outcomes assessment of the critically ill population is to study long-term patterns of recovery and function. Unfortunately, this effort is partially frustrated by a lack of standardisation in the variables recorded. In a review on this subject, Black et al described 161 different outcome measures in the ICU literature but concluded that only 11 of these should be recommended for further use 4 . Though originally intended to assess outcome following head injury 5 , the Glasgow outcome score has subsequently been widely used at follow-up to assess recovery of function in various clinical scenarios including the general ICU population 6 . Scores from 1 (death) to 5 (return to normal activity) are recorded. A more detailed measure of independent capacity is the karnofsky score. This instrument was originally used to measure functional status in cancer patients 7 , but has subsequently been widely used in outcome studies. It allows meaningful assessment of performance status and has been validated in the ICU population 6, 8 . Often a Glasgow outcome score of 4 to 5 and a karnofsky index score of 70 to 100 are considered to constitute 'good recovery' 6 . In the overdose population, who are often younger than the average ICU patient, return to work is also an appropriate parameter to consider. The 11 measurement variables advocated by Black et al included the Glasgow outcome score, karnofsky index and return to work. We thus chose to measure these three variables to assess functional status and recovery of a cohort of patients admitted to our ICU during a three-year period for management of drug overdose. We contacted the patients or their representatives for interview two years after that period had ended. In this study, we describe our findings.
METHODS
This study was conducted in the ICU of an 18-bed inner-city, university-affiliated tertiary referral hospital. Following approval from the local ethics committee, we performed a retrospective review of a prospectively recorded database of all ICU admissions at our centre, to identify all cases of illicit drug overdose admitted during the years 2004 to 2006. We also reviewed the charts of all patients admitted to the ICU following cardiac arrest or aspiration injury over the same period, with a review of toxicology data to identify other relevant cases. From the database we recorded patient age, type of drug or drugs taken, severity of illness (Acute Physiology and Chronic Health Evaluation II [APACHE II] score) and survival to ICU discharge. We attempted to trace these patients, using personal contact data or those of their next-ofkin or general practitioners, to obtain follow-up data.
Surviving patients who consented were interviewed by telephone using a structured format to measure Glasgow outcome score, karnofsky Index and work status (see Appendix 1 on the website version).
Statistical analysis was performed using the JMPin 5.1 ® software package. For tests of significance, the χ 2 test, the independant t-test, the Wilcoxon rank sums test and Spearmans correlation were used. normality was assessed using the Sharpiro-Wilks test. A two-sided P value <0.05 was deemed statistically significant.
RESULTS
From 1 January 2004 to 31 December 2006 there were 43 (31/43 or 72% male) patients admitted to the Mater Hospital ICU due to overdose. Of these, four were classified as aspiration pneumonia, two as seizures, nine as cardiac arrests and the remaining 28 simply as overdose. The individual details of each case are shown in Table 1 .
Alcohol was present in 21% of cases, but when alcohol was excluded 44% of patients had taken a single class of drug and 56% had mixed overdoses. The mean (SD) age was 34.1 (13.1) and APACHE II score 16.7 (7.1). There was no significant difference between mean age in males (33.2 [12.3] ) versus females (36.3 [15.5]) (P=0.65). There was a 25.6% ICU mortality with a mean (SD) ICU stay of 5.1 (4.9) days. There was no significant difference in gender (P=0.47), APACHE II score (P=0.36), age at presentation (P=0.85) or single versus multiple drug overdose (P=0.42) in ICU survivors versus non-survivors.
Follow-up data were obtained on all patients. The total mortality at time of follow-up was 44.2%, with a median (IQR) follow-up time of 31 (20 to 37) months from time of ICU discharge/ICU death. All who survived their ICU stay were discharged alive from hospital. Of the 32 patients who survived their initial ICU/hospital stay, 75% were male, with a mean length of 4.7 (4.9) days spent in ICU and a mean APACHE II score of 16.3 (7.7).
At a median (IQR) follow-up of 31 (20 to 37) months, a further 8/32 (25%) had died. Of the remaining 24 patients, 13 were living in the community but unemployed and four were serving custodial sentences. The remaining seven patients were working and one of these was undertaking further education. Of the total group the median (IQR) Glasgow outcome score was 4 (1 to 5) and karnofsky performance index 60 (0 to 80). For the surviving patients at the point of follow-up the values were 4.5 (4 to 5) and 80 (70 to 90), respectively. 
DISCUSSIOn
We found that a quarter of patients admitted to our ICU following overdose died there, but that all who survived ICU were discharged alive from hospital. This mortality figure is higher than described in most series in the relevant literature. In a US-based study, Heyman and colleagues reported a mortality rate of only 5% in a population admitted to a medical ICU for overdose management 9 . However their cohort was markedly less ill than that in our study; a mean APACHE II score of 8 was reported, with only 12% of the group requiring mechanical ventilation. Perhaps a more meaningful comparison is with the findings of a UK study by Waters et al, who described an ICU mortality rate of 17.5% while also suggesting that APACHE II scores poorly reflect the mortality risk in the overdose population 10 . The hospital mortality rate we describe is at least compatible with the original APACHE II description 11 (predicting mortality rates around 25% for scores of 15 to 19); nonetheless, we were surprised to find such a high rate in the present day. The length of stay similarly reflects the severity of their physiologic derangement.
The present study was undertaken in an innercity Dublin teaching hospital. While estimates of opioid use are inevitably crude, especially where it is criminalised, a study in 1996 estimated that there were approximately 13,460 opiate users in Dublin 12 . In addition, there are over 5000 people registered on methadone treatment programs in Ireland, the vast majority of these in the greater Dublin area. In this drug-using culture there is a high incidence of codependance on benzodiazepines, with 54% of opioid users also abusing benzodiazepines in one series 13 . Broadly consistent with this, in our study 60% of patients who tested positive for opioids were also positive for benzodiazepines. While heroin remains the major drug of abuse in Ireland, and indeed across Europe where there are an estimated 1 to 1.5 million addicts, there has been a large recent increase in cocaine usage 14 . In the current study, 21% of patients tested positive for cocaine, while 14% had taken cocaine as a single agent.
Seen in the context of such high levels of nonprescription drug use, the numbers of patients presenting to our ICU service are small. It is likely that they represent the most extreme patterns of abuse or deliberate self-poisoning as their high ICU mortality (25%) and mean APACHE II score of 16.7 indicate very severe physiologic disorder. Such events in young people should be recognised as indicative of the most high-risk behaviour and would ideally lead to major efforts at rehabilitation. Indeed, the provision of ICU services generally, which are amongst the most expensive forms of medical treatment, should optimally be followed by the highest quality and most supportive, multidisciplinary outpatient care.
Psychiatric consultation is arranged for all patients presenting to this institution following overdose as part of a multimodal care strategy, prior to their leaving ICU. nonetheless, the outcomes after discharge as described in the current study are poor. At three years follow-up, patients who survived their inital overdose were more likely to be dead than employed. For a cohort with an average age of 34 years, in a modern western society, this is a striking finding. In a Scandanavian study of deliberate selfpoisoning, published over 20 years ago, the authors found a suicide rate of 10% during three years follow-up, most of which were through drug overdose 15 . Although their data mostly describe the ingestion of prescription drugs, the excessive mortality rate they observed is comparable to that of our study.
The number who were in custody, one in six of those alive at follow-up, is also noteworthy. Since most of the group were by defintition involved in crime by virtue of the drugs they consumed (Table 1) , it is clear that their underlying level of criminality is very high. It is not possible therefore to draw reliable conclusions about changes in this aspect of their behaviour from our data. We believe that asking patients or their relatives about previous or background criminality was unlikely to yield reliable data.
In various chronic disease conditions it has been found that acute exacerbations requiring ICU admission reliably identify patients at higher risk of mortality. This is most widely recognised in asthma 16 and chronic obstructive airways disease 17 , but has also been demonstrated in pulmonary fibrosis 18 , cancer 19 and cirrhosis 20 for example. A compelling argument is made that substance addiction should be regarded as a chronic illness per se, and treated as such 21 . Seen from this perspective, our observations are compatible with those made in other diseases showing that the requirement for ICU admission is associated with a poor prospect for long-term survival even if the patient survives their present exacerbation. Our findings thus arguably validate this novel view of substance addiction as a long-term illness 21 .
There are significant limitations to our study. The findings represent the case-mix of a single ICU within a large urban teaching centre. We did not attempt to stratify overdose into deliberate and accidental, due to obvious difficulties validating such data with our study design (many patients presenting comatose and 44% being dead at time of follow-up). It is likely that many fatal overdoses never reach ICU, or indeed hospital, and in certain cases relevant patients may have been transferred elsewhere (e.g. paracetamol overdoses to the regional liver transplant centre). It is also possible that other patients were admitted due to overdose in the period studied under other diagnostic categories (e.g. trauma). Although we attempted to minimise this possibility by searching the database for aspiration injuries, cardiac arrests and those presenting with seizures, there are nonetheless other diagnostic categories that may have included cases of overdose that went undetected with this approach. Furthermore, overdoses of less common agents may inadvertantly have been missed due to the specific nature of current toxicology testing.
Nonetheless, as a readily identifiable group, the overdose patients presenting to ICU in our series appear to be at a high risk of death in both the immediate and longer term. The allocation of medical resources that ICU admission entails should logically be followed up by the highest quality, multidisciplinary care with a view to rehabilitation and resolution of causative or contributary factors. The role of follow-up clinics for patients admitted to ICU services remains controversial and is currently under study 22 . It is possible that the current patient subgroup, in view of their youth and apparently poor long-term outcomes, might gain particular benefit from intensive and co-ordinated multidisciplinary support and intervention. We believe this warrants further investigation.
